InCarda at BIO CEO & Investor Conference

February 11, 2019 – New York, NY

At the BIO CEO and Investor Conference, Dr. Grace Colón was a panelist for a discussion on “Attacking Biological Mechanisms of Aging to Extend Healthspan” where she discussed a range of topics including the correlated risks of aging to developing atrial fibrillation and InCarda’s unique treatment in development for patients suffering from paroxysmal atrial fibrillation (PAF).

In addition, Dr. Colon gave an overall corporate presentation on InCarda, highlighting the company’s unique approach to addressing key unmet needs in atrial fibrillation as well as progress towards key company milestones.

Held in NYC annually, The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.